In a small clinical trial in the US, it was discovered that an experimental cancer drug could cure cancer patients. According to a study published in The New England Journal of Medicine, 12 patients, all diagnosed with rectal cancer, Dostarlimab over a six-month period †experimental drug† after receipt entered the healing process.

One of the journal’s lead authors, Dr. Luis Diaz told The New York Times, “This is the first time in the history of cancer treatment.“While the scientists are excited about the study, they are hopeful that the results will come out,” he said. More experiments need to be done and warned against the conclusion that the cancer had been eradicated permanently. Let’s look at the details together.

After a 2-year period in the experiment, the cancer cells were completely destroyed.

dostarlimab, in the treatment of endometrial cancer It is an immune system therapy medicine used in rectal cancer It was the first clinical trial to determine whether it could be effective against tumors. The drug unmasks cancer cells, allowing the immune system to identify and destroy them.

12 patients for six months before the study received dostarlimab every three weeks† Normally, this treatment would be followed by standard chemotherapy and surgery, but based on patient feedback, it was concluded that this was not necessary.

Six months after patients stop taking the drug, cancer cells can be detected by physical examination, endoscopy, PET or MRI scans. disappeared unnoticed† Two years after the study, patients recovered from cancer. seems to be fully recovered† As a result, none of the study participants has yet have not had chemotherapy or surgery† What do you think? Please don’t forget to share your thoughts with us in the comments.